BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2630254)

  • 1. Neurophysiological studies of L-acetylcarnitine administration in man.
    Gambi D; Onofrj M; Calvani M; Faricelli A; Del Re ML; Bazzano S; Cutarella R; Fulgente T; Colangelo U
    Drugs Exp Clin Res; 1989; 15(9):435-46. PubMed ID: 2630254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of levo-acetylcarnitine on P300-like potentials of the normal monkey.
    Onofrj M; Ghilardi MF; Faricelli A; Bodis-Wollner I; Calvani M
    Drugs Exp Clin Res; 1987; 13(7):407-15. PubMed ID: 3652929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of L-acetyl carnitine HCl on rat steady-state visual evoked potentials. Comparison with L-carnitine.
    Onofrj M; Bodis-Wollner I; Calvani M
    Drugs Exp Clin Res; 1987; 13(1):5-13. PubMed ID: 3595444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of acetyl-L-carnitine in the treatment of cognitive deficit in chronic alcoholism.
    Tempesta E; Troncon R; Janiri L; Colusso L; Riscica P; Saraceni G; Gesmundo E; Calvani M; Benedetti N; Pola P
    Int J Clin Pharmacol Res; 1990; 10(1-2):101-7. PubMed ID: 2201652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaco-electroencephalographic and clinical effects of the cholinergic substance--acetyl-L-carnitine--in patients with organic brain syndrome.
    Herrmann WM; Dietrich B; Hiersemenzel R
    Int J Clin Pharmacol Res; 1990; 10(1-2):81-4. PubMed ID: 2201660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modality-specific changes in P300 parameters in patients with dementia of the Alzheimer type.
    Pokryszko-Dragan A; Słotwiński K; Podemski R
    Med Sci Monit; 2003 Apr; 9(4):CR130-4. PubMed ID: 12709671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurophysiological effects of recombinant interferon-gamma and -alpha in man.
    Born J; Späth-Schwalbe E; Pietrowsky R; Porzsolt F; Fehm HL
    Clin Physiol Biochem; 1989; 7(3-4):119-27. PubMed ID: 2509123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacodynamics of acetyl-L-carnitine in patients with Parkinson's disease.
    Puca FM; Genco S; Specchio LM; Brancasi B; D'Ursi R; Prudenzano A; Miccoli A; Scarcia R; Martino R; Savarese M
    Int J Clin Pharmacol Res; 1990; 10(1-2):139-43. PubMed ID: 2387661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurological and neurophysiological effects of oral isotretinoin: a prospective investigation using auditory and visual evoked potentials.
    Aydogan K; Turan OF; Onart S; Yazici B; Karadogan SK; Tokgoz N
    Eur J Dermatol; 2008; 18(6):642-6. PubMed ID: 18955197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visually and auditory evoked EEG potentials in carriers of four hereditary EEG variants.
    Vogel F; Krüger J; Höpp HP; Schalt E; Schnobel R
    Hum Neurobiol; 1986; 5(1):49-58. PubMed ID: 3700148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Auditory and visual event-related potentials in patients suffering from Alzheimer's dementia and multiinfarct dementia, before and after treatment with piracetam.
    Dabic-Jeftic M; Mikula I
    Funct Neurol; 1993; 8(5):335-45. PubMed ID: 8144060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a single, short intravenous dose of acetyl-L-carnitine on pattern-reversal visual-evoked potentials in cirrhotic patients with hepatic encephalopathy.
    Siciliano M; Annicchiarico BE; Lucchese F; Bombardieri G
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):76-80. PubMed ID: 16445703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motoneurone recurrent inhibition is enhanced by L-acetylcarnitine in humans.
    Schieppati M; Gritti I; Mazzocchio R; Rossi A; Mancia M
    Electromyogr Clin Neurophysiol; 1989 Mar; 29(2):73-80. PubMed ID: 2707143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of acetyl-L-carnitine on reaction times in patients with cerebrovascular insufficiency.
    Arrigo A; Casale R; Buonocore M; Ciano C
    Int J Clin Pharmacol Res; 1990; 10(1-2):133-7. PubMed ID: 2387660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Exposure to traffic noise and effects on attention].
    Tomei G; Tecchio F; Zappasodi F; Ercolani M; Moffa F; Chiovenda P; Ciarrocca M
    Ann Ig; 2006; 18(6):507-19. PubMed ID: 17228608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The use of 1-acetylcarnitine in (presenile and senile) Alzheimer's disease. Preliminary results].
    Acierno G
    Clin Ter; 1983 Apr; 105(2):135-45. PubMed ID: 6345054
    [No Abstract]   [Full Text] [Related]  

  • 17. Decrease of evoked delta, theta and alpha coherences in Alzheimer patients during a visual oddball paradigm.
    Güntekin B; Saatçi E; Yener G
    Brain Res; 2008 Oct; 1235():109-16. PubMed ID: 18598686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of the postexcitatory cortical inhibition upon paired-click auditory stimulation in patients with Parkinson's disease.
    Lukhanina EP; Kapustina MT; Berezetskaya NM; Karaban IN
    Clin Neurophysiol; 2009 Oct; 120(10):1852-8. PubMed ID: 19767236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of levo-acetyl-carnitine on visual cognitive evoked potentials in the behaving monkey.
    Antal A; Bodis-Wollner I; Ghilardi MF; Glover A; Mylin L; Toldi J
    Electroencephalogr Clin Neurophysiol; 1993 Apr; 86(4):268-74. PubMed ID: 7682930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative analysis of sensory visual evoked oscillations with visual cognitive event related oscillations in Alzheimer's disease.
    Yener GG; Güntekin B; Tülay E; Başar E
    Neurosci Lett; 2009 Oct; 462(3):193-7. PubMed ID: 19616074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.